Ignite Creation Date:
2024-05-06 @ 8:41 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02797977
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2016-05-23
Brief Title:
A Phase 12 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Sponsor:
Organization:
Sierra Oncology LLC - a GSK company